Welcome to LookChem.com Sign In|Join Free

CAS

  • or

489471-57-0

Post Buying Request

489471-57-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

489471-57-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 489471-57-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,9,4,7 and 1 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 489471-57:
(8*4)+(7*8)+(6*9)+(5*4)+(4*7)+(3*1)+(2*5)+(1*7)=210
210 % 10 = 0
So 489471-57-0 is a valid CAS Registry Number.

489471-57-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-imidazol-1-ylsulfonyl-3-methylimidazol-3-ium,trifluoromethanesulfonate

1.2 Other means of identification

Product number -
Other names trifluoromethanesulfonate, 1-imidazol-1-ylsulfonyl-3-methylimidazol-3-ium

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:489471-57-0 SDS

489471-57-0Relevant articles and documents

Preparation of unsymmetrical sulfonylureas from N,N′-sulfuryldiimidazoles

Beaudoin, Serge,Kinsey, Kenneth E.,Burns, James F.

, p. 115 - 119 (2003)

The synthetic methods reported in the literature for the preparation of sulfonylureas tend to be restricted in scope or unsuitable for use in parallel synthesis. We have developed a method for preparing sterically congested sulfonylureas based on N,N′-sul

1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

-

Paragraph 383-385, (2021/09/03)

The present invention relates to a novel compound having a histone deacetylase 6 (HDAC6) inhibitory activity, an isomer thereof or a pharmaceutically acceptable salt thereof, the use thereof for preparing a therapeutic medicament; a pharmaceutical composition containing the same, and a treatment method using the composition; and a preparation method thereof. The novel compound, the isomer thereof, or the pharmaceutically acceptable salt thereof according to the present invention has the HDAC6 inhibitory activity, which is effective in the prevention or treatment of HDAC6-mediated diseases including cancer, inflammatory diseases, autoimmune diseases, neurological or neurodegenerative diseases.

Sulfuryl Fluoride Mediated Conversion of Aldehydes to Nitriles

Gurjar, Jitendra,Bater, Jorick,Fokin, Valery V.

supporting information, p. 1906 - 1909 (2019/01/24)

Aliphatic, aromatic, and heteroaromatic aldehydes were readily converted to corresponding nitriles in a one-pot reaction sequence with hydroxylamine and sulfuryl fluoride. The reaction proceeds at room temperature, does not require metal catalysts and special precautions, and produces nitriles in excellent yields. It is compatible with a variety of functional groups, can be performed in aqueous and organic solvents, and is readily scalable to multigram quantities. Mild conditions and high selectivity of the reaction enabled the construction of polyfunctional probes containing nitrile, alkyne, azide, and fluorosulfate groups for further orthogonal derivatization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 489471-57-0